 BOSTON--BUSINESS WIRE--Gamida Cell Ltd. Nasdaq: GMDA, the leader in the development of NAM-enabled cell therapy candidates for patients with hematologic and solid cancers and other serious diseases, announces that Michele Korfin, Chief Operating Officer and Chief Commercial Officer, will present its corporate highlights at the annual Cell Gene Meeting on the Mesa to be held October 11-13, 2022 in Carlsbad, California and livestreamed globally. Ms. Korfin will discuss 2022 catalysts an 